Pantec Biosolutions Granted European Patent for P.L.E.A.S.E
Thomas Bragagna, CTO of Pantec Biosolutions, commented: “We are delighted that Pantec has been granted this patent. After receiving CE marking and marketing clearance for P.L.E.A.S.E. last year, it is important for us to know that our key technology is now protected by patent laws.”
Pantec Biosolutions currently has an additional 19 applications pending in the USA, Europe and Japan. The Company plans to further develop its patent portfolio with the help of a well-balanced IP strategy in order to focus on current and future applications within the most important markets.
Most read news
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.